Year | Author | Methodology | Population | Measure | Results | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Country | Recruitment setting | Sex (male, %) | Age (mean) | Genotype (SS, %) | Type | Name | Cut-off | N total | % depressed | ||
1999 | Wilson Schaeffer, J. J et al | USA | Outpatient | 43.86 | 33.70 | PA | CES-D 20 | 16 | 440 | 43.41 | |
2000 | Grant et al | USA | Outpatient | 41.86 | 35.02‡ | PA | CES-D 20 | 16 | 43 | 25.58 | |
2003 | Hasan et al | USA | Outpatient | 54.00 | 36.00 | 94.00 | PA | BDI-II | 14 | 50 | 44.00 |
2005 | Jenerette et al | USA | Cohort | 28.00 | 35.00 | PA | BDI 7 | 4 | 221 | 31.67 | |
2006 | Laurence et al | USA | Cohort | 43.54 | 79.40 | PA | CES-D 10 | 4 | 101 | 38.61 | |
2007 | Pells, J. et al | USA | Cohort | 36.82 | PA | LEMFPSCD (BDI-II) | 14 | 67 | 35.82 | ||
2008 | Levenson et al | USA | Cohort | 38.40 | 34.00 | 70.96 | PA | PHQ 9 | 10 | 232 | 27.59 |
2009 | Carroll et al | USA | Inpatient | 36.50‡ | 24.10‡ | MRR | n/a | 122 | 6.56 | ||
2009 | Edwards et al | USA | Outpatient | 36.82 | PA | LEMFPSCD (BDI-II) | 14 | 67 | 22.00 | ||
2010 | Anie et al | Nigeria | Outpatient | PA | PISCD | n/a | 253 | 44.27 | |||
2010 | Asnani et al | Jamaica | Cohort | 49.46 | 31.00 | PA | BDI-II | 14 | 277 | 21.66 | |
2010 | Kamble et al | USA | Outpatient | 42.96 | 34.20 | PA | BDI-II | 14 | 142 | 35.21 | |
2010 | Mahdi et al | Bahrain | Outpatient | 42.80 | 17.23‡ | 100 | PA | DASS 21 | 10 | 243 | 59.26 |
2011 | Carroll et al | USA | Inpatient | MRR | n/a | 1874 | 4.27 | ||||
2011 | Treadwell et al | USA | Outpatient | 31.20 | PA | PHQ 9 | 10 | 77 | 61.04 | ||
2012 | Rosine | Europe | Outpatient | 44.30 | 35.60 | 100† | PA | BDI-II | 14 | 89 | 49.44 |
2012 | Vilela et al | Brazil | Outpatient | 32.00 | 35.00 | 100 | PA | BDI-II | 20 | 24 | 16.67 |
2013 | Gibson et al | Jamaica | Outpatient | 48.00 | 36.40 | 70.00 | PA | BDI-II | 17 | 143 | 13.29 |
2014 | Morgan et al | Jamaica | Outpatient | 35.97 | 69.60 | PA | BDI-II | 14 | 140 | 15.00 | |
2014 | Wallen et al | USA | Cohort | 49.00 | 34.00 | 85.00† | PA | BDI-II | 16 | 315 | 20.63 |
2015 | Mann-Jiles et al | USA | Outpatient | 49.00 | 64.00 | MRR | n/a | 72 | 19.44 | ||
2015 | Mastandréa et al | Brazil | Outpatient | 38.20 | 30.00 | 72.70† | PA | PHQ 9 | 10 | 110 | 30.00 |
2015 | Treadwell et al | USA | Cohort | 40.00 | 31.60 | 73.00 | PA | PHQ 9 | 10 | 77 | 32.47 |
2016 | Al Sherawi et al | Oman | Outpatient Inpatient | 34.00 | PA | BDI-II | 14 | 123 | 39.02 | ||
2016 | Anim et al | Ghana | Outpatient | 51.00 | 65.00 | PA | BSI | ? | 201 | 0.00 | |
2016 | Fayand et al | Europe | Inpatient | 43.00 | 27.00 | MRR | n/a | 439 | 5.24 | ||
2016 | Ola et al | Nigeria | Outpatient | 38.83 | 25.30 | 98.06 | PA | PHQ 9 | 5 | 103 | 71.84 |
2016 | Master et al | USA | Outpatient | 48.00 | 33.00 | PA | PROMIS | 55 | 100 | 35.00 | |
2016 | Raji et al | Nigeria | Outpatient | 46.30 | 25.37 | Interview | Mini | n/a | 205 | 16.59 | |
2017 | Adam et al | USA | Outpatient | 28.00 | 35.40 | 56.00 | PA | BDI-II | 14 | 142 | 35.21 |
2017 | Dorociak et al | USA | Outpatient | 22.20 | 40.61 | PA | CES-D 20 | 16 | 54 | 38.89 | |
2018 | Alhomoud et al | Saudi Arabia | Outpatient | 57.30 | 31.70 | 100 | PA | BDI-II | 14 | 110 | 48.18 |
2018 | Alsubaie et al | Saudi Arabia | Outpatient | 35.90 | 26.40 | PA | HAM-D 17 | 8 | 78 | 85.90 | |
2018 | Ahmadi et al | Iran | Outpatient | 35.10 | 64.90 | PA | DASS 21 | 5 | 97 | 67.01 | |
2018 | Williams et al | USA | Inpatient | 52.00 | 27.50 | Interview | ED-Scan | n/a | 95 | 29.47 | |
2018 | Simo et al | USA | VOC | 20.00 | 80.00 | PA | PHQ 9 | 10 | 10 | 50.00 |